DICE Therapeutics Stock (NASDAQ: DICE)
|Day Range19.49 - 20.72||52 Wk Range12.64 - 25.92||Open / Close19.56 / 20.28||Float / Outstanding28.1M / 38.2M|
|Vol / Avg.363.9K / 399K||Mkt Cap774.9M||P/E-||50d Avg. Price18.6|
|Div / Yield-||Payout Ratio-||Total Float28.1M||EPS-0.58|
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of DICE Therapeutics (NASDAQ: DICE) through any online brokerage.
The latest price target for DICE Therapeutics (NASDAQ: DICE) was reported by Cantor Fitzgerald on Wednesday, September 14, 2022. The analyst firm set a price target for 36.00 expecting DICE to rise to within 12 months (a possible 77.51% upside). 4 analyst firms have reported ratings in the last year.
The stock price for DICE Therapeutics (NASDAQ: DICE) is $20.28 last updated September 30, 2022, 8:00 PM UTC.
There are no upcoming dividends for DICE Therapeutics.
DICE Therapeutics’s Q3 earnings are confirmed for Thursday, November 10, 2022.
There is no upcoming split for DICE Therapeutics.
DICE Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.